European Journalof Musculoskeletal Diseases

Vol. 2, No 1, January - June 2013 ISSN 2038-4106/2013

Published byBiolife

www.b io l i f esas .o rg

Janu

ary

- Jun

e 20

13Vo

l. 2,

No

1Eu

rope

an J

ourn

al o

f Mus

culo

skel

etal

Dis

ease

s

European Journal of Musculoskeletal Diseases

Volume 2, no.1 January-June 2013

A. Migliore. Editorial: What is the best way to measure the impact of intra-articular therapy on osteoarthritis?............................................................................................................................

R. Laurenti, F. Giovannangeli, E. Gubinelli, M. T. Viviano, A. Errico, L. Leoni, E. Ballanti, A. Migliore. Long-term safety of anti-TNF etanercept in patients with psoriatic arthritis and concurrent HBV infection; a case series of 10 patients..................................................................

L. Novelli, C. Ciccacci, P. Borgiani, G. Novelli. Recent advances in the genetic susceptibility to Osteoarthritis..............................................................................................................................

S. Bellando-Randone, S. Guiducci, M.L. Conforti, J. Blagojevic, G. Salvadorini, G. Fiori, F. Bartoli, F. Nacci, A, Candelieri, C, Bruni, A. Moggi Pignone, M. Matucci-Cerinic. Sildenafil and Raynaud’s phenomenon (RP) in Systemic Sclerosis (SSc): results from a retrospective study

D. Orlandi, F. Lacelli, N. Perrone, G. Marino, C. Mazzola, E. Silvestri, L. Maria Sconfienza, G.Serafini. Feasibility of ultrasound-guided injection of platelet-rich plasma to treat patellar tendinopathy in athletes: preliminary results..................................................................................

F. Di Stani, C. Ojango, A.G. Ruggeri, L. Di Lorenzo, M. Pappagallo, R. Fiori, A.M.V. Fiore, R. Delfini, and S. Masala. The rationale of analgesic intra-articular injections in osteoarthritis pain

A. Allam. Letter to the editor.........................................................................................................

1

3

9

21

27

35

49

Car

avag

gio

“Inc

redu

lità

di S

an T

omm

aso”